Tag: oral solid dosage contract manufacturing market report

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Oral Solid Dosage Contract Manufacturing Market from 2024 to 2033?
The oral solid dosage contract manufacturing market size has shown strong growth in recent years. It is projected to grow from $36.70 billion in 2023 to $39.39 billion in 2024, at a CAGR of 7.3%. This growth is linked to the increasing global population, prevalence of chronic diseases, and a focus on research and development.

The oral solid dosage contract manufacturing market is expected to reach $52.94 billion in 2028 with a CAGR of 7.3%. Growth factors include increasing outsourcing by pharmaceutical companies and advancements in drug delivery technology. Key trends involve 3D printing integration and controlled-release technologies.

Claim Your Free Sample of the Global Oral Solid Dosage Contract Manufacturing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

What Key Factors Are Fueling the Growth of the Oral Solid Dosage Contract Manufacturing Market?
The rising demand for generic drugs is expected to spur the growth of the oral solid dosage contract manufacturing market. This demand is driven by patent expirations and regulatory incentives, making generic drugs more accessible. Contract manufacturing enhances operational efficiency and reduces costs in producing generic medications. The FDA estimated that 91% of prescriptions in the U.S. were for generic drugs in 2022, with over 32,000 generic drugs approved. Thus, the demand for generic drugs is fueling the oral solid dosage contract manufacturing market.

What Are the Major Segments of the Oral Solid Dosage Contract Manufacturing Market?
1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies

What New Trends Are Transforming the Oral Solid Dosage Contract Manufacturing Market?
Major companies in the oral solid dosage contract manufacturing market are working on innovative solutions such as continuous manufacturing lines to strengthen their market position. Continuous manufacturing lines enable more efficient production of pharmaceuticals. For instance, in January 2023, WuXi STA launched its first continuous manufacturing line for oral solid products, enhancing efficiency and quality in drug manufacturing.

Order Now for Fast Delivery of Your Oral Solid Dosage Contract Manufacturing Market Report!
https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Regions Are Driving Growth in the Oral Solid Dosage Contract Manufacturing Market?
Asia Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Oral Solid Dosage Contract Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oral solid dosage contract manufacturing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Oral Solid Dosage Contract Manufacturing Market Include

1. Oral Solid Dosage Contract Manufacturing Market Executive Summary
2. Oral Solid Dosage Contract Manufacturing Market Segments
3. Oral Solid Dosage Contract Manufacturing Market Size And Template Market Growth Rate
4.  Key Oral Solid Dosage Contract Manufacturing Market Trends
5. Major Oral Solid Dosage Contract Manufacturing Market Drivers
……
25. Key Mergers And Acquisitions In The Oral Solid Dosage Contract Manufacturing Market
26. Top Oral Solid Dosage Contract Manufacturing Companies
27. Oral Solid Dosage Contract Manufacturing Market Opportunities And Strategies
28. Oral Solid Dosage Contract Manufacturing Market, Conclusions And Recommendations
29. Appendix

Discover Related Reports by The Business Research Company:
Electronic Contract Manufacturing and Design Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/electronic-contract-manufacturing-and-design-services-global-market-report

Food Contract Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-contract-manufacturing-global-market-report

Medical Device Contract Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-device-contract-manufacturing-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Oral Solid Dosage Contract Manufacturing Global Market Report 2024, the oral solid dosage contract manufacturing market is expected to show promising growth in the forecast period.

The oral solid dosage contract manufacturing market has experienced significant growth in recent years and is poised for further expansion. As of 2023, the market size was valued at $36.70 billion and is expected to reach $39.39 billion by 2024, reflecting a compound annual growth rate (CAGR) of 7.3%. This robust growth is driven by several factors including an increasing global population, the rising prevalence of chronic diseases, and heightened focus on research and development. Looking ahead, the market is projected to grow to $52.94 billion by 2028, maintaining the same CAGR of 7.3%. The future growth can be attributed to increased outsourcing by pharmaceutical companies, advancements in drug delivery technologies, and heightened drug development activities.

Key Drivers of Market Growth

• Outsourcing by Pharmaceutical Companies: Many pharmaceutical companies are increasingly outsourcing their manufacturing processes to focus on core competencies, such as drug discovery and development. This trend is expected to continue, driving demand for oral solid dosage contract manufacturing.
• Advancements in Drug Delivery Technology: Innovations in drug delivery systems, such as controlled-release technologies and 3D printing, are enhancing the efficiency and effectiveness of drug delivery, contributing to market growth.
• Increasing Drug Development Activities: The rise in drug development activities, driven by the need for new and effective treatments, is fueling demand for contract manufacturing services.

Rising Demand for Generic Drugs
The demand for generic drugs is a major factor propelling the growth of the oral solid dosage contract manufacturing market. Generic drugs, which are bioequivalent to brand-name drugs, are increasingly favored due to their cost-effectiveness and patent expirations. This demand is supported by regulatory incentives and expanding healthcare access. For instance, in 2022, the FDA reported that 91% of prescriptions in the USA were filled with generic drugs. The contract manufacturing sector plays a crucial role in producing and distributing these generics by enhancing operational efficiency and reducing costs. This trend is expected to drive market growth as the industry continues to meet the rising demand for affordable medications.

View More On The Oral Solid Dosage Contract Manufacturing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Major Companies and Innovations

• Innovative Manufacturing Solutions: Leading companies in the oral solid dosage contract manufacturing market are investing in innovative solutions to maintain competitiveness. For example, WuXi STA, a Chinese pharmaceutical company, launched its first continuous manufacturing line for oral solid products in January 2023. This state-of-the-art facility leverages continuous manufacturing processes to enhance production efficiency, quality, and flexibility.
• Strategic Acquisitions: In August 2022, Catalent Inc. acquired Metrics Contract Services for $475 million, aiming to boost its capabilities in oral solid dosage forms. This acquisition highlights the trend of strategic expansions to enhance manufacturing capabilities and meet the growing demand.

Market Segmentation
The oral solid dosage contract manufacturing market is segmented into various categories:

1. By Product Type: Includes tablets, capsules, powders, granules, and other types.
2. By Service: Encompasses drug product development, fill-finish product manufacturing, API manufacturing, packaging and labeling, among others.
3. By Therapeutic Area: Covers oncology, cardiovascular diseases, metabolic disorders, neurological disorders, infectious diseases, gastrointestinal diseases, and other areas.
4. By End User: Differentiates between large companies and medium/small-sized companies.

Regional Insights
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The region’s growth is driven by its expanding pharmaceutical industry and increasing outsourcing trends.

In conclusion, the oral solid dosage contract manufacturing market is on a strong growth trajectory, fueled by rising demand for generic drugs, technological advancements, and strategic industry developments. As pharmaceutical companies continue to seek efficient and cost-effective manufacturing solutions, the market is set to expand further in the coming years.

Request A Sample Of The Global Oral Solid Dosage Contract Manufacturing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16137&type=smp